Antibody response to human immunodeficiency virus after primary infection
- PMID: 3553344
- DOI: 10.1093/infdis/155.6.1113
Antibody response to human immunodeficiency virus after primary infection
Abstract
The antibody response to human immunodeficiency virus (HIV) after primary infection was monitored in eight homosexual men with the acute mononucleosis-like illness associated with seroconversion. Multiple sera from each subject, taken at frequent intervals after onset of acute illness, were tested for antibody to HIV by IgM and IgG immunofluorescent assays (IFAs), four commercial enzyme-linked immunosorbent assays (ELISAs), and Western immunoblot (WB). Antibody to HIV was detected first by IgM IFA (mean +/- SD, 5 +/- 3 days), followed by IgG IFA (11 +/- 3 days); the IgM antibody titer peaked at 24 +/- 17 days and disappeared by 81 +/- 27 days, whereas the IgG antibody titer peaked at 133 +/- 63 days and has not disappeared in any subject. Antibody to HIV was first detected by ELISA from 31 +/- 14 to 58 +/- 32 days, depending on the assay kit used. Antibody to p24 and gp41 was first detected by WB at 24 +/- 10 days, followed by antibody to p55 (40 +/- 20 days), p68 (57 +/- 19 days), and p34 (71 +/- 22 days).
Similar articles
-
Serological study of subjects with seroconversion to human immunodeficiency virus.Eur J Clin Microbiol Infect Dis. 1988 Apr;7(2):144-8. doi: 10.1007/BF01963067. Eur J Clin Microbiol Infect Dis. 1988. PMID: 3134201
-
Diagnostic value of specific IgM antibodies in primary HIV infection.AIDS. 1988 Feb;2(1):31-5. doi: 10.1097/00002030-198802000-00005. AIDS. 1988. PMID: 3128993
-
Detection of anti-HIV-1 immunoglobulin M antibodies in patients with serologically proved HIV-1 infection.Infection. 1988 Mar-Apr;16(2):115-8. doi: 10.1007/BF01644317. Infection. 1988. PMID: 3163678
-
Detection of immunoglobulin M antibody in primary human immunodeficiency virus infection.AIDS. 1988 Feb;2(1):11-5. doi: 10.1097/00002030-198802000-00002. AIDS. 1988. PMID: 3128992
-
[HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].Wien Klin Wochenschr. 1987 Aug 7;99(15):536-9. Wien Klin Wochenschr. 1987. PMID: 3310415 Review. German.
Cited by
-
Superinfection of a chimpanzee with a second strain of human immunodeficiency virus.J Virol. 1987 Dec;61(12):4026-9. doi: 10.1128/JVI.61.12.4026-4029.1987. J Virol. 1987. PMID: 2446009 Free PMC article.
-
Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.J Virol. 2008 Aug;82(15):7700-10. doi: 10.1128/JVI.00605-08. Epub 2008 May 28. J Virol. 2008. PMID: 18508902 Free PMC article.
-
Structural insights on the role of antibodies in HIV-1 vaccine and therapy.Cell. 2014 Feb 13;156(4):633-48. doi: 10.1016/j.cell.2014.01.052. Cell. 2014. PMID: 24529371 Free PMC article. Review.
-
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.J Virol. 2008 Dec;82(24):12449-63. doi: 10.1128/JVI.01708-08. Epub 2008 Oct 8. J Virol. 2008. PMID: 18842730 Free PMC article.
-
New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.J Clin Microbiol. 1990 Sep;28(9):2022-9. doi: 10.1128/jcm.28.9.2022-2029.1990. J Clin Microbiol. 1990. PMID: 2121790 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical